Advertisement

Literatur

  • Hans W. Doerr
Conference paper
  • 9 Downloads
Part of the Sitzungsberichte der Heidelberger Akademie der Wissenschaften book series (HD AKAD, volume 1978 / 1)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Albrecht, T., Rapp, F.: Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology 55, 53–61 (1973)PubMedCrossRefGoogle Scholar
  2. 2.
    Alford, C.A.: The immunologic status of the newborn. Hosp. Pract. 5, 88–92 (1970)Google Scholar
  3. 3.
    Alford, C.A., Jr., Stagno, S., Reynolds, D.W.: Diagnosis of chronic perinatal infections. Amer. J. Dis. Child. 129, 455–463 (1975)PubMedGoogle Scholar
  4. 4.
    Al-Nakib, W., Best, J.M., Banatvala, J.E.: Rubella-specific serum and nasopharyngeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM. Lancet 1975 I, 182–185CrossRefGoogle Scholar
  5. 5.
    Andersen, H.K.: Complement-fixing and virus neutralizing antibodies in cytomegalovirus infections as measured against homologous and heterologous antigens. Acta path. microbiol. scand. B 78, 504–508 (1970)Google Scholar
  6. 6.
    Aurelian, L.: Possible role of herpesvirus hominis, Type 2, in human cervical cancer. Fed. Proc. 31, 1651–1659 (1972)PubMedGoogle Scholar
  7. 7.
    Back, A.F., Schmidt, N.J.: Reactivity of envelope, capsid, and soluble antigens of herpesvirus hominis types 1 and types 2 in the indirect hemagglutination test. Infect. Immun. 10, 102–106 (1974)PubMedGoogle Scholar
  8. 8.
    Bekessy, A., Molineaux, L., Storey, J.: Estimation of incidence and recovery rates of Plasmodium falciparum parasitaemia from longitudinal data. Bull. Wld Hlth Org. 54, 685–690 (1976)Google Scholar
  9. 9.
    Benjamin, D.R.: Rapid typing of herpes simplex virus strains using the indirect immunoperoxidase method. Appl. Microbiol. 28, 568–571 (1974)PubMedGoogle Scholar
  10. 10.
    Berger, J.: Zur Infektionskinetik bei Toxoplasmose, Röteln, Mumps und Zytomegalie. Zbl. Bakt., I. Abt. Orig. A 224, 503–522 (1973)Google Scholar
  11. 11.
    Berger, J.: Anwendung mathematischer Verfahren in der Epidemiologie von Infektionskrankheiten. Studien anhand eines mathematischen Modells. In: Kirchhoff-Langer (Hrsg.): Toxoplasmose. Prakt. Fragen und Ergebnisse. Stuttgart: G. Thieme-Verlag 1971Google Scholar
  12. 12.
    Birnbaum, G., Lynch, J.I., Margileth, A.M., Longergan, W.M., Sever, J.L.: Cytomegalovirus infections in newborn infants. J. Pediat. 75, 789–795 (1969)PubMedCrossRefGoogle Scholar
  13. 13.
    Bonin, O.: Quantitativ-virologische Methodik. Stuttgart: G. Thieme-Verlag 1973Google Scholar
  14. 14.
    British Medical Research Council: BCG and vole bacillus vaccines in the presention of tuberculosis in adolescence and early adult life. Bull. Wld Hlth Org. 46, 371–385 (1972)Google Scholar
  15. 15.
    Butler, W.R.: The epidemiological approach to intrauterine infections. In: Ciba Foundation Symposium 10 (new series), 1974Google Scholar
  16. 16.
    Craig, C.P., Nahmias, J.: Different patterns of neurologic involvement with herpes simplex virus types 1 and 2: Isolation of herpes simplex type 2 from the buffy coat of two adults with meningitis. J. infect. Dis. 127, 365–372 (1973)PubMedCrossRefGoogle Scholar
  17. 17.
    Darai, G., Munk, K.: Human embryonic lung cells abortively infected with herpesvirus hominis type 2 show some properties of cell transformation. Nature (Lond.) New Biol. 241, 268–269 (1973)CrossRefGoogle Scholar
  18. 18.
    Doerr, H.W.: Neutralisierende Coxsackievirus B-Antikörper bei Myokarditis und Pleurodynie. Dtsch. med. Wschr. 98, 1396–1400 (1973)PubMedCrossRefGoogle Scholar
  19. 19.
    Doerr, H.W., Gross, G., Schmitz, H., Enders, G.: Neutralising serum IgM antibodies in infections with herpes simplex virus hominis. Med. Microbiol. Immunol. 162, 183–192 (1976)PubMedCrossRefGoogle Scholar
  20. 20.
    Doerr, H.W., Haas, R., Mross, F., Baron, M., et al.: Quantitativer und virusspezifischer IgM-Nachweis in Nabelschnurblut Neugeborener. Immun. Infekt. 6, 278–280 (1975)Google Scholar
  21. 21.
    Doerr, H.W., Lehmair, H., Schmitz, H., Kampa, D., Luthardt, Th.: Simple mathematical deductions in the seroepidemiology of viral infections. I. Herpesvirus group (Herpesvirus hominis, Varicella-Zoster-Virus, Cytomegalovirus, Epstein-Barr-Virus). Zbl. Bakt., I. Abt. Orig. A 238, 149–164 (1977)Google Scholar
  22. 22.
    Doerr, H.W., Rau, M., Schmitz, H.: Typing of herpesvirus simplex hominis 1 and 2 by indirect immunofluorescence. Med. Microbiol. Immunol. 159, 137–140 (1974)PubMedCrossRefGoogle Scholar
  23. 23.
    Doerr, H.W., Schmitz, H., Petersen, E.E.: Antikörperbildung gegen das Nukleokapsid und das Envelope des Herpes simplex Virus hominis. Zbl. Bakt., I. Abt. Orig. A 227, 348–354 (1974)Google Scholar
  24. 24.
    Doerr, H.W., Schweiss, H.-D., Henninger, K., Sochanik, H.: Simple mathematical deductions in the seroepidemiology of viral infections. II. (Para)Myxovirus (Measles, Mumps, Influenza B), rubella, enteroviruses (Polio, Coxsackie), adenoviruses, and mycoplasma pneumoniae. Zbl. Bakt., I. Abt. Orig. A 238, 165–176 (1977)Google Scholar
  25. 25.
    Duff, R., Rapp, F.: Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2. J. Virol. 8, 469–477 (1971)PubMedGoogle Scholar
  26. 26.
    Elek, S.D., Stern, H.: Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero. Lancet 1974I, 1–5Google Scholar
  27. 27.
    Embil, J.A., Ozere, R.L., Haldane, E.V.: Congenital cytomegalovirus infection in two siblings from consecutive pregnancies. J. Pediat. 77, 417–42 (1970)PubMedCrossRefGoogle Scholar
  28. 28.
    Enders, G.: Röteln und Schwangerschaft. Gynäkologe 10, 15–30 (1975)Google Scholar
  29. 29.
    Enders, G.: Masernstandardserum — Ringversuch. Med. Landesunters.-Amt, Stuttgart (1975)Google Scholar
  30. 30.
    Enders, G., Haas, R., Luthardt, Th.: Virusinfektionen in der Schwangerschaft. Med. Klin. 68, 1643–1646 (1973)Google Scholar
  31. 31.
    European group for rapid laboratory viral diagnosis: XVI. Symposium of the European Association against virus diseases. Amsterdam 1977Google Scholar
  32. 32.
    Evans, A.S., Niederman, J.C., McCollum, R.W.: Seroepidemiologic studies of infectious mononucleosis with EB virus. New Engl. J. Med. 279, 1121–1127 (1968)PubMedCrossRefGoogle Scholar
  33. 33.
    Frenkel, N., Roizman, B., Cassai, E., et al.: A DNA fragment of herpes simplex 2 and its transcription in human cervical cancer tissue. Proc. nat. Acad. Sci. (Wash.) 69, 3784–3789 (1972)CrossRefGoogle Scholar
  34. 34.
    Falk, W., Glawogger, F.: Rötelnvirus- und Zytomegalievirus-Durchseuchung der weiblichen Bevölkerung. Wien. med. Wschr. 17/18, 267–271 (1974)Google Scholar
  35. 35.
    Feorino, P.M., Palmer, E.L.: Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls. J. infect. Dis. 127, 732–735 (1973)PubMedCrossRefGoogle Scholar
  36. 36.
    Fiala, M., Edmondson, L., Guze, L.B.: Simplified method for insolation of cytomegalovirus and demonstration of frequent viremia in renal transplant patients. Proc. Soc. exp. Biol. (N.Y.) 144, 871–875 (1973)Google Scholar
  37. 37.
    Forghani, B., Schmidt, N.J., Lennette, E.H.: Solid-phase radioimmunoassay for identification of herpesvirus hominis types 1 and 2 from clinical materials. Appl. Microbiol. 28, 661–667 (1974)PubMedGoogle Scholar
  38. 38.
    Geder, I., Skinner, G.R.B.: Differentiation between type 1 and type 2 strains of herpes simplex virus by an indirect immunofluorescent technique. J. gen. Virol. 12, 179–182 (1971)PubMedCrossRefGoogle Scholar
  39. 39.
    Geigy, A.G., Pharma: Documenta Geigy. 7. Auflage. Basel 1969Google Scholar
  40. 40.
    Golubjatnikow, R., Allen, V.D., Steadman, M., Blancarte, M.D.P.O., Inhorn, S.L.: Prevalence of antibodies to Epstein-Barr-virus, Cytomegalovirus, and Toxoplasma in a mexican highland community. Amer. J. Epidem. 97, 116–124 (1972)Google Scholar
  41. 41.
    Gupta, P., Jeor, S.St., Rapp, R.: Comparsion of the polypeptides of serveral strains of human cytomegalovirus. J. gen. Virol. 34, 447–454 (1977)PubMedCrossRefGoogle Scholar
  42. 42.
    Haas, R., Doerr, H.W., Petersen, E.E., Schmitz, H.: Über die Vergleichbarkeit virusserologischer Befunde. Ein Beitrag zur Frage des Standardprinzipes in der Virusdiagnostik. Bundesgesundheitsblatt 20, 189–294 (1977)Google Scholar
  43. 43.
    Haas, R., Petersen, E.E., Neumann, D., Doerr, H.W., et al.: Untersuchungen über die Immunitätslage gegen Poliomyelitis. Ergebnisse einer kooperativen Studie der Deutschen Vereinigung zur Bekämpfung der Kinderlähmung und anderer Viruskrankheiten. Dtsch. med. Wschr. 100, 3–8 (1975)PubMedCrossRefGoogle Scholar
  44. 44.
    Haines, H.G., Essen, R. v., Benyesh-Melnick, M.: Preparation of specific antisera to cytomegaloviruses in goats. Proc. Soc. exp. Biol. (N.Y.) 138, 846–849 (1971)Google Scholar
  45. 45.
    Hairston, N.G.: On the mathematical analysis of shistosome populations. Bull. Wld Hlth Org. 33, 45–62 (1965)Google Scholar
  46. 46.
    Hanshaw, J.B.: Herpesvirus hominis infections in the fetus and the newborn. Amer. J. Dis. Child. 126, 546–565 (1973)PubMedGoogle Scholar
  47. 47.
    Hanshaw, J.B., Schultz, F.W., Melish, M.M., Dudgeon, J.A.: Congenital cytomegalovirus infection. In: Intrauterine infections. Ciba Foundation Symposium 10 (new series) 1974Google Scholar
  48. 48.
    Hanshaw, J.B., Steinfeld, H.I., White, C. J.: Fluorescent antibody test for Cytomegalovirus macroglobulin. New Engl. J. Med. 12, 566–570 (1968)CrossRefGoogle Scholar
  49. 49.
    Hayward, G.S., Frenkel, N., Roizman, B.: Herpes simplex virus DNA: strain differences and heterogeneity in the location of the restriction endonuclease cleavage sites. Proc. nat. Acad. Sci. (Wash.) 72, 1768–1772 (1975)CrossRefGoogle Scholar
  50. 50.
    Henle, G., Henle, W.: Immunofluorescence in cells derived from Burkitt’s lymphoma. J. Bact. 91, 1248–1256 (1966)PubMedGoogle Scholar
  51. 51.
    Henle, G., Henle, W., Clifford, P., Diehl, V., et al.: Antibodies to Epstein-Barr virus in Burkitt’s lymphoma and control groups. J. nat. Cancer Inst. 43, 1147–1157 (1969)PubMedGoogle Scholar
  52. 52.
    Henneberg, G., Antoniadis, G.: Virologische Untersuchungen über das Vorkommen von komplementbindenden Antikörpern gegen das Cytomegalievirus in Berlin-West. Zbl. Bakt. I. Abt. Orig. 213, 416–427 (1970)Google Scholar
  53. 53.
    Ho, M., Suwansirikul, S., Dowling, J.N., Youngbland, L.A., Armstrong, J.A.: The transplanted kidney as a source of cytomegalovirus infection. New Engl. J. Med. 22, 1109–1112 (1975)CrossRefGoogle Scholar
  54. 54.
    Honess, R.W., Powell, K.L., Robinson, D.J., Sim, C., Watson, D.H.: Type specific and type common antigens in cells infected with herpes simplex virus type 1 and on the surfaces of naked and enveloped particles of the virus. J. gen. Virol. 22, 159–169 (1974)PubMedCrossRefGoogle Scholar
  55. 55.
    Huang, E.S., Chen, S.T., Pagano, J.S.: Human cytomegalovirus I. Purification and characterization of viral DNA. J. Virol. 12, 1473–1481 (1973)PubMedGoogle Scholar
  56. 56.
    Huang, Y.T., Huang, E.S., Pagano, J.S.: Antisera to human cytomegaloviruses prepared in the guinea pigs: Specific immunofluorescence and complement fixation tests. J. Immunol. 112, 528–532 (1974)PubMedGoogle Scholar
  57. 57.
    Huang, E.S., Kilpatrick, B.A., Huang, Y.T., Pagano, J.S.: Detection of human cytomegalovirus and analysis of strain variation. Yale J. Biol. Med. 49, 29–44 (1975)Google Scholar
  58. 58.
    Ipsen, J., Feigl, P.: A biomathematical model for prevalence of trichomonas vaginalis. Amer. J. Epidem. 91, 1975–1985 (1970)Google Scholar
  59. 59.
    Joncas, J.H.: Clinical significance of the EB herpesvirus infection in man. Progr. med. Virol. 14, 200–240 (1972)Google Scholar
  60. 60.
    Joncas, J.H., Menezes, J., Huang, E.S., Pagano, J.S.: Persistent CMV and EBV genomes in lymphoblastoid cell lines from an infant, after congenital infection. Third International Congress for Virology, Madrid, 1975Google Scholar
  61. 61.
    Just, M., Buergin-Wolff, A., Emoedi, G., Hernandez, R.: Immunisation trials with live attenuated cytomegalovirus twon 125. Infect. 3, 111–114 (1975)CrossRefGoogle Scholar
  62. 62.
    Kalimo, K.O.K., Marttila, R.J., Granfors, G., Viljanen, M.: Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens. Infect. Immun. 15, 883–889 (1977)PubMedGoogle Scholar
  63. 63.
    Kalimo, K.O.K., Ziola, B.R., Viljanen, M.K., Granfors, K., Toivanen, P.: Solidphase radio-immunoassay of herpes simplex virus IgG and IgM antibodies. J. Immunol. Methods 14, 183–195 (1977)PubMedCrossRefGoogle Scholar
  64. 64.
    Kilpatrick, B.A., Huang, E.S., Pagano, J.S.: Analysis of cytomegalovirus genomes with restriction endonucleoses Hin D III and Eco R-1. J. Virol. 18, 1095–1105 (1976)PubMedGoogle Scholar
  65. 65.
    Klein, G.: Herpesviruses and oncogenesis. Proc. nat. Acad. Sci. (Wash.) 69, 1056–1064 (1972)CrossRefGoogle Scholar
  66. 66.
    Klein, R.J.: Pathogenetic mechanisms of recent herpes simplex virus infections. Arch. Virol. 51, 1–13 (1976)PubMedCrossRefGoogle Scholar
  67. 67.
    Krech, U., Jung, M.: Antigenic relationship between human herpes viruses. Arch. ges. Virusforsch. 33, 288–295 (1971)PubMedCrossRefGoogle Scholar
  68. 68.
    Krech, U.H., Jung, M., Jung, F.: Cytomegalovirus infections of man. Basel: S. Karger Verlag 1971Google Scholar
  69. 69.
    Krech, U., Konjajev, Z., Jung, M.: Congenital cytomegalovirus infection in siblings from consecutive pregnancies. Helv. paediat. Acta 26, 355–362 (1971)PubMedGoogle Scholar
  70. 70.
    Lafaye, A.: Un model exponentiel simple la fonction catalytique en epidemiométrie tuberculinique. Bull. Org. mond. Santé 54, 633–643 (1976)Google Scholar
  71. 71.
    Lamerz, R., Fateh-Mogadam, A., Knedel, M.: Zur quantitativen immunologischen Bestimmung von Serumproteinen. Z. klin. Chem. 11, 491–496 (1973)Google Scholar
  72. 72.
    Lang, D.J.: Cytomegalovirus infections in organ transplantation and post transfusion. Arch. ges. Virusforsch. 37, 365–377 (1972)PubMedCrossRefGoogle Scholar
  73. 73.
    Langenhuysen, M.M.A.C., Thé, T.H., Neweg, H.O., Kapsenberg, J.G.: Demonstration of IgM cytomegalovirus antibodies as an aid to early diagnosis in adults. Clin. exp. Immunol. 6, 387–393 (1970)PubMedGoogle Scholar
  74. 74.
    Leinikki, P.: Immunofluorescent assay of herpesvirus type 1 and 2 antibodies in rabbit and human sera. Arch. ges. Virusforsch. 35, 349–355 (1971)CrossRefGoogle Scholar
  75. 75.
    Lennette, E.H., Schmidt, N.J. (Hrsgb.): Diagnostic procedures for viral and rickettsial infections. Amer. Publ. Hlth Ass., 4. Auflage, 1969Google Scholar
  76. 76.
    Luthardt, Th.: Cytomegalic Bücherei des Pädiaters, Heft 75. Stuttgart: F. Enke-Verlag 1976Google Scholar
  77. 77.
    Luthardt, Th., Neufang, A., Neufang, G., Reussner, L.: Cytomegalic-Virus-Infektionen im Säuglingsalter. Epidemiologie-Diagnostik-Klinik. Mschr. Kinderheilk. 122, 500–501 (1974)PubMedGoogle Scholar
  78. 78.
    MacDonald, G.: The dynamics of helmith infections with special reference to shistosomes. Trans. roy. Soc. trop. Med. Hyg. 69, 489–506 (1965)CrossRefGoogle Scholar
  79. 79.
    Martin, M.L., Palmer, E.L., Kissling, R.E.: Complement-fixing antigens of herpes simplex virus types 1 and 2: Reactivity of capsid, envelope, and soluble antigens. Infect. Immun. 5, 248–254 (1972)PubMedGoogle Scholar
  80. 80.
    Marx, J.L.: Cytomegalovirus: A major cause of birth defects. Science 190, 1184–1186 (1975)Google Scholar
  81. 81.
    Miller, G.: Epstein-Barr herpesvirus and infectious mononucleosis. Progr. med. Virol. 20, 84–112 (1975)Google Scholar
  82. 82.
    Muench, H.: Catalytic models in epidemiology. Cambridge/Mass.: Harvard University Press 1959Google Scholar
  83. 83.
    Nahmias, A., Del Buono, I., Pipkin, J., Hutton, R., Wickliffe, C.: Rapid indentification and typing of herpes simplex virus types 1 and 2 by a direct immunofluorescence technique. Appl. Microbiol. 22, 455–458 (1971)PubMedGoogle Scholar
  84. 84.
    Nahmias, A.J., Del Buono, I., Schneweis, K.E., Gordon, D.S., Thies, D.: Typespecific surface antigens of cells infected with herpes simplex virus (1 and 2). Proc. Soc. exp. Biol. (N.Y.) 138, 21–27 (1971)Google Scholar
  85. 85.
    Nahmias, A.J., Dowdle, W.R.: Antigenic and biologic differences in herpesvirus hominis. Progr. med. Virol. 10, 110–159 (1968)Google Scholar
  86. 86.
    Nahmias, A.J., Josey, W.L., Naib, Z.M., Luce, G.F., Duffey, A.: Antibodies to herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections. Amer. J. Epidem. 91, 539–546 (1970)Google Scholar
  87. 87.
    Nahmias, A.J., Josey, W.E., Naib, Z.M., Luce, C.F., Guest, B.A.: Antibodies to herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer. Amer. J. Epidem. 91, 547–552 (1970)Google Scholar
  88. 88.
    Nahmias, A.J., Roizman, B.: Infection with herpes-simplex viruses 1 and 2. New Engl. J. Med. 289, 667–674 (I), 719–725 (II), 781–789 (III) (1973)PubMedCrossRefGoogle Scholar
  89. 89.
    Naib, Z.M., Nahmias, A.J., Josey, W.E.: Cytology and histopathology of cervical herpes simplex. Cancer (Philad.) 19, 1026–1040 (1966)CrossRefGoogle Scholar
  90. 90.
    Nasemann, Th.: Viruskrankheiten der Haut, der Schleimhäute und des Genitales. Stuttgart: G. Thieme-Verlag 1974Google Scholar
  91. 91.
    Pagano, J.S.: Diseases and mechanisms of persistant DNA virus infection: Latency and cellular transformation. J. infect. Dis. 132, 209–223 (1975)PubMedCrossRefGoogle Scholar
  92. 92.
    Pagano, J.S.: Prevention of infections with cytomegalovirus. Yale J. Biol. Med. 49, 59–62 (1976)PubMedGoogle Scholar
  93. 93.
    Palmer, E.L., Martin, M.L., Warfield, D.T.: Preparation of type 2 herpes simplex virus complement-fixing antigen. Appl. Microbiol. 22, 925–927 (1971)PubMedGoogle Scholar
  94. 94.
    Paul, J.R., White, C.: Serological epidemiology. New York and London: Academic press 1973Google Scholar
  95. 95.
    Pauls, F.P., Dowdle, W.: A serologic study of herpesvirus hominis strains by micro-neutralization tests. J. Immunol. 98, 941–947 (1967)PubMedGoogle Scholar
  96. 96.
    Pereira, L., Cassai, E., Honess, R.W., Roizman, B., et al.: Variability in the structural polypeptides of herpes simplex virus 1 strains: Potential application in molecular epidemiology. Infect. Immun. 13, 211–220 (1976)PubMedGoogle Scholar
  97. 97.
    Pflanz, M.: Allgemeine Epidemiologie. Stuttgart: G. Thieme-Verlag 1973Google Scholar
  98. 98.
    Plotkin, S., Furukawa, T., Zygraich, N., Vamos, E., Haygden, C.: Candidate cytomegalovirus strain for vaccination. Infect. Immun. 12, 521–527 (1975)PubMedGoogle Scholar
  99. 99.
    Plummer, G.: A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera. Cancer Res. 33 1469–1476 (1973)PubMedGoogle Scholar
  100. 100.
    Plummer, G.: Cytomegaloviruses of man and animals. Progr. med. Virol. 15, 92–125 (1973)Google Scholar
  101. 101.
    Pope, J.H., Horne, M.K., Scott, W.: Identification of the filtrable leucocyte-transforming factor of QIMRWIL cells as herpes-like virus. Int. J. Cancer 4, 255–260 (1969)PubMedCrossRefGoogle Scholar
  102. 102.
    Quevedo, M., Todt, R., Luthardt, Th., Siebert, W.: Cytomegalievirus-KBR in der Mikrotechnik. Ärztl. Lab. 8, 293–299 (1971)Google Scholar
  103. 103.
    Rapp, F., Duff, R.: In vitro cell transformation by herpes viruses. Fed. Proc. 31, 1660–1668 (1972)PubMedGoogle Scholar
  104. 104.
    Ratcliffe, J.: The differentiation of herpes simplex virus type 1 and type 2 by temperature markes. J. gen. Virol. 13, 181–183 (1971)PubMedCrossRefGoogle Scholar
  105. 105.
    Rawls, W.E., Iwamoto, K., Adam, E., Melnick, J.L.: Measurement of antibodies to herpesvirus types 1 and 2 in human sera. J. Immunol. 104, 599–606 (1969)Google Scholar
  106. 106.
    Rawls, W.E., Tompkins, W.A.F., Figueroa, M.E., Melnick, J.L.: Herpesvirus type 2 — Association with carcinoma of the cervix. Science 161, 1255–1256 (1968)PubMedCrossRefGoogle Scholar
  107. 107.
    Rowe, W.P., Hartley, J.W., Waterman, S., Turner, A.C., Huebner, R.J.: Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc. Soc. exp. Biol. (N.Y.) 92, 418–424 (1956)Google Scholar
  108. 108.
    Schmidt, N.J., Forghani, B., Lennette, E.H.: Type specifity of complement-requiring and immunoglobulin M neutralizing antibody in initial herpes simplex virus infections of humans. Infect. Immun. 12, 728–732 (1975)PubMedGoogle Scholar
  109. 109.
    Schmitz, H., Doerr, H.W., Kampa, D., Vogt, A.: Solid-phase enzyme-immunoassay for IgM antibodies to cytomegalovirus. J. clin. Microbiol. 5, 629–634 (1977)PubMedGoogle Scholar
  110. 110.
    Schmitz, H., Doerr, H.W., Obrig, M.: Envelope and nucleocapsid antigens of cytomegalovirus (CMV). Med. Microbiol. Immunol. 161, 155–162 (1975)PubMedCrossRefGoogle Scholar
  111. 111.
    Schmitz, H., Kampa, D., Doerr, H.W., Luthardt, Th., Wuertele, A.: IgM antibodies to cytomegalovirus during pregnancy. Arch. Virol. 53, 177–184 (1977)PubMedCrossRefGoogle Scholar
  112. 112.
    Schmitz, H., Krainick-Riechert, C.M.: Simple detection of fluorescent stained IgM in sucrose gradients: Demonstration of virus-specific IgM. Intervirol. 3, 353–358 (1974)CrossRefGoogle Scholar
  113. 113.
    Schmitz, H., Haas, R.: Determination of different cytomegalovirus immunoglobulins (IgA, IgG, IgM) by immunofluorescence. Arch. ges. Virusforsch. 37, 131–140 (1972)PubMedCrossRefGoogle Scholar
  114. 114.
    Schmitz, H., Scherer, M.: IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch. ges. Virusforsch. 37, 332–339 (1972)PubMedCrossRefGoogle Scholar
  115. 115.
    Schneweis, K.E., Brandis, H.: Typendifferenzen beim Herpes simplex Virus. Zbl. Bakt., I. Abt. Orig. 183, 556–558 (1961)Google Scholar
  116. 116.
    Schneweis, K.E., Nahmias, A.J.: Antigens of herpes simplex virus type 1 and 2 -immunodiffusion and inhibition passive hemagglutination studies. Z. Immun.-Forsch. 141, 471–487 (1970)Google Scholar
  117. 117.
    Schneweis, K.E., Reynolds, J.D., Rosskopp, D., Sommerhäuser, H.: Vergleichende Typisierung von Herpes simplex-Virus-Stämmen mit serologischen und biologischen Methoden. Zbl. Bakt., I. Abt. Orig. A 227, 331–338 (1974)Google Scholar
  118. 118.
    Schneweis, K.E., Wolff, M.H., Marklein, G., Stifter, G.: Untersuchungen mit der IgM-Fraktion von Patientenseren bei verschiedenen Viruserkrankungen. Z. Immun.-Forsch. 147, 236–249 (1974)Google Scholar
  119. 119.
    Sever, J.L. (Hrsgb.): Immunological responses to perinatal infections. J. Pediat. 75, 111 ff (1969)Google Scholar
  120. 120.
    Skare, J., Summers, W.P., Summers, W.C.: Structure and function of herpes virus genomes. I. Camparison of five HSV-1 and two HSV-2 strains by cleavage of their DNA with Eco RI restriction endonuclease. J. Virol. 15, 726–732 (1975)PubMedGoogle Scholar
  121. 121.
    Skinner, G.R.B., Hartley, C., Whitney, J.E.: Detection of type-specific antibody to herpes simplex virus 1 and 2 in human sera by complement-fixation tests. Arch. Virol. 50, 323 (1976)PubMedCrossRefGoogle Scholar
  122. 122.
    Skinner, G.R.B., Thouless, M.E., Trueman, S., Edwards, J., Gibbs, A.J.: Serological relatedness of herpes simplex viruses; type-specifity of antibody response. Immunology 31, 481–494 (1976)PubMedGoogle Scholar
  123. 123.
    Skinner, G.R.B., Whitney, J.E., Hartley, C.: Prevalence of type-specific antibody against type 1 and 2 herpes simplex virus in women with abnormal cervical cytology; evidence towards pre-pubertal vaccination of sero-negative female subjects. Arch. Virol. 54, 211–221 (1977)PubMedCrossRefGoogle Scholar
  124. 124.
    Smith, I.W., Pentherer, J.F., MacCallum, F.O.: The incidence of herpesvirus hominis antibodies in the population. J. Hyg. Canb. 65, 305–407 (1967)Google Scholar
  125. 125.
    Sohier, R., Freund, R.J., De-Thé, G., Day, N.E., et al.: Seroepidemiology of herpesvirus type Epstein-Barr in blood donors from communities around Lyon. Amer. J. Epidem. 99, 414–424 (1973)Google Scholar
  126. 126.
    Stagno, S., Reynolds, D.W., Alford, C.A.: Congenital cytomegalovirus (CMV) infection in two consecutive pregnancies. Clin. Res. 21, 124 (1973)Google Scholar
  127. 127.
    Stern, H., Elek, S.D.: The incidence of infection with cytomegalovirus in a normal population. A serological study in Greater London. J. Hyg. (Lond.) 63, 79–87 (1965)CrossRefGoogle Scholar
  128. 128.
    Stern, H., Tucker, S.M.: Prospective study of cytomegalovirus infection in pregnancy. Brit. med. J. 1973I, 268–270Google Scholar
  129. 129.
    Stiess, G., Berthold, H.: Immunglobuline bei der akuten Hepatitis. Verh. dtsch. Ges. inn. Med. 79, 635–637 (1973)PubMedGoogle Scholar
  130. 130.
    Stoll, H.U.: Zytomegalievirusausscheidung bei gesunden Kindern im ersten Lebensjahr. Schweiz. med. Wschr. 104, 468–472 (1974)PubMedGoogle Scholar
  131. 131.
    Styblo, K., Meijer, J., Sutherland, A.: La transmission du bacille tuberculeux. Bull. Org. mond. Santé 41, 137–178 (1969)Google Scholar
  132. 132.
    Sugino, W.M., Kingsbury, D.T.: DNA homologies between strains of herpes simplex virus. Virology 71, 605–608 (1976)PubMedCrossRefGoogle Scholar
  133. 133.
    Sumaya, C.V., Henle, H., Henle, G., Smith, M.H.D., LeBlanc, D.: Seroepidemiological study of Epstein-Barr-virus infections in a rural community. J. infect. Dis. 131, 403–408 (1974)CrossRefGoogle Scholar
  134. 134.
    Tomlinson, A.H., MacCallum, F.O.: The incidence of complement-fixing antibodies to varicella-zoster virus in hospital patients and blood doners. J. Hyg. (Lond.) 68, 411–416 (1970)CrossRefGoogle Scholar
  135. 135.
    Traenhart, O., Höher, P.G., Kuwert, E.: Der epidemiologische Aussagewert der katalytischen Wachstumskurve für Populationsimmunität und Impfindikation am Beispiel einer Polio-Typ I-Epidemie im Ruhrgebiet. Z. med. Mikrobiol. Immunol. 156, 175–193 (1971)CrossRefGoogle Scholar
  136. 136.
    U.S. Department of Health, Education and Welfare: CDC standard rubella hemagglutination inhibition test. Centor f. Disease Control, Atlanta (1970)Google Scholar
  137. 137.
    Voller, A., Bidwell, D.E.: Enzyme-immunoassay for antibodies in measles, cytomegalovirus infections and after rubella vaccination. Brit. J. exp. Path. 57, 243–247 (1976)PubMedGoogle Scholar
  138. 138.
    Weller, T.H., Hanshaw, J.B., Scott, D.E.: Serologic differentiation of viruses responsible for cytomegalic inclusion disease. Virology 12, 130–132 (1960)PubMedCrossRefGoogle Scholar
  139. 139.
    Wentworth, B.B., Alexander, E.R.: Seroepidemiology of infections due to members of the herpesvirus group. Amer. J. Epidem. 94, 496–507 (1971)Google Scholar
  140. 140.
    Wilkie, N.M., Clements, J.B., Macnab, J., Subak-Sharpe, J.H.: The structure and biological properties of herpes simplex virus DNA. Cold Spr. Harb. Symp. quant. Biol. 39, 657–666 (1974)CrossRefGoogle Scholar
  141. 141.
    Wolf, H.: A procedure for simultaneous preparation of large amounts of DNA and RNA by the use of potassium iodide gradients. Analyt. Biochem. 68, 505–511 (1975)PubMedCrossRefGoogle Scholar
  142. 142.
    Zur Hausen, H.: Oncogenic Herpes viruses (Übersicht). Biochim. Biophys. Acta (Amst.) 417, 25–53 (1975)Google Scholar
  143. 143.
    Zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., et al.: EB-virus DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature (Lond.) 228 1056–1057 (1970)CrossRefGoogle Scholar

Addendum

  1. 144.
    Doerr, H.W., Künzler, A., Schmitz, H.: Cytomegalovirus (CMV) strain differentiation by DNA restriction analysis. Oncology (im Druck)Google Scholar
  2. 145.
    Künzler, A.: Cytomegalievirus: Stammdifferenzierung und Virusgenomnachweis im Urin. Inaug.-Diss., Freiburg 1977Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1978

Authors and Affiliations

  • Hans W. Doerr
    • 1
  1. 1.Institut für Medizinische VirologieIm Neuenheimer FeldHeidelbergDeutschland

Personalised recommendations